In this research, the prognostic impact of traditional factors like tumour grades, histological types, and IDH mutation status on glioma was evaluated, which are integral in determining treatment approaches including grading prognosis and selecting therapies like immunotherapy, radiotherapy and chemotherapy. Here, IDH1 is linked to central nervous system cancer.